Agios Pharmaceuticals, Inc. (AGIO) stock analysis

AGIO · Agios Pharmaceuticals, Inc.

Latest recorded price: USD 30.15

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth 56.0%, free cash flow margin -698.3%, ROIC -130.4%. The model flags 2 risk signals for this company (1 high severity).

Similar companies in Healthcare